# New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors

> **NCT03895099** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Intercommunal Creteil** · enrollment: 110 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Desogestrel early follicular phase
- **DRUG:** Desogestrel medium follicular phase
- **DRUG:** Desogestrel ovulatory phase
- **DRUG:** Desogestrel late follicular phase
- **DRUG:** Desogestrel luteal phase

## Key facts

- **NCT ID:** NCT03895099
- **Lead sponsor:** Centre Hospitalier Intercommunal Creteil
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-04
- **Primary completion:** 2023-10-30
- **Final completion:** 2023-10-30
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2023-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03895099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03895099, "New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03895099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*